BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 7704916)

  • 1. Dissociated control by glycyrrhizin of proliferation and IL-2 production of murine thymocytes.
    Zhang YH; Kato M; Isobe K; Hamaguchi M; Yokochi T; Nakashima I
    Cell Immunol; 1995 Apr; 162(1):97-104. PubMed ID: 7704916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycyrrhizin as a promoter of the late signal transduction for interleukin-2 production by splenic lymphocytes.
    Zhang YH; Isobe K; Nagase F; Lwin T; Kato M; Hamaguchi M; Yokochi T; Nakashima I
    Immunology; 1993 Aug; 79(4):528-34. PubMed ID: 8406577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel activation pathway for mature thymocytes. Costimulation of CD2 (T,p50) and CD28 (T,p44) induces autocrine interleukin 2/interleukin 2 receptor-mediated cell proliferation.
    Yang SY; Denning SM; Mizuno S; Dupont B; Haynes BF
    J Exp Med; 1988 Oct; 168(4):1457-68. PubMed ID: 3049912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the immunoregulatory action of saikosaponin-d.
    Kato M; Pu MY; Isobe K; Iwamoto T; Nagase F; Lwin T; Zhang YH; Hattori T; Yanagita N; Nakashima I
    Cell Immunol; 1994 Nov; 159(1):15-25. PubMed ID: 7954839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of the CD28 activation pathway on the immunosuppressive action of cyclosporine.
    Hess AD; Bright EC
    Transplantation; 1991 Jun; 51(6):1232-40. PubMed ID: 1646506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different mechanisms of activation of proliferating CD3+ cells in patients with lymphoproliferative disease of granular lymphocytes.
    Zambello R; Cassatella MA; Trentin L; Bulian P; Siviero F; Feruglio C; Agostini C; Vespignani M; Chisesi T; Pizzolo G
    Leukemia; 1991 Nov; 5(11):942-50. PubMed ID: 1835747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defective thymic T cell activation by concanavalin A and anti-CD3 in autoimmune nonobese diabetic mice. Evidence for thymic T cell anergy that correlates with the onset of insulitis.
    Zipris D; Lazarus AH; Crow AR; Hadzija M; Delovitch TL
    J Immunol; 1991 Jun; 146(11):3763-71. PubMed ID: 1827815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Murine thymocytes with ability to inhibit Il-2 production: I. Genetic differences between mouse strains and characterization of the model system.
    Gigliotti D; Nihlmark EL; Wigzell H; Hansson M
    APMIS; 1992 Jan; 100(1):71-80. PubMed ID: 1531594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early precursor thymocytes can produce interleukin 2 upon stimulation with calcium ionophore and phorbol ester.
    Lugo JP; Krishnan SN; Sailor RD; Rothenberg EV
    Proc Natl Acad Sci U S A; 1986 Mar; 83(6):1862-6. PubMed ID: 3081905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proliferation and production of IL-2 and B cell stimulatory factor 1/IL-4 in early fetal thymocytes by activation through Thy-1 and CD3.
    Tentori L; Pardoll DM; Zuñiga JC; Hu-Li J; Paul WE; Bluestone JA; Kruisbeek AM
    J Immunol; 1988 Feb; 140(4):1089-94. PubMed ID: 2893823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-12 is involved in the activation of CD3+ granular lymphocytes in patients with lymphoproliferative disease of granular lymphocytes.
    Zambello R; Trentin L; Cassatella MA; Raimondi R; Cerutti A; Enthammer C; Facco M; Agostini C; Semenzato G
    Br J Haematol; 1996 Feb; 92(2):308-14. PubMed ID: 8602990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Entry of CD4-CD8- immature thymocytes into the CD4/CD8 developmental pathway is controlled by tyrosine kinase signals that can be provided through TCR components.
    Takahama Y; Hasegawa T; Itohara S; Ball EL; Sheard MA; Hashimoto Y
    Int Immunol; 1994 Oct; 6(10):1505-14. PubMed ID: 7826942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth-promoting activity of IL-1 alpha, IL-6, and tumor necrosis factor-alpha in combination with IL-2, IL-4, or IL-7 on murine thymocytes. Differential effects on CD4/CD8 subsets and on CD3+/CD3- double-negative thymocytes.
    Suda T; Murray R; Guidos C; Zlotnik A
    J Immunol; 1990 Apr; 144(8):3039-45. PubMed ID: 1969882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of anti-CD3 antibody-induced mouse T cell activation by pentoxifylline in combination with rapamycin or A77 1726 (leflunomide).
    Richard M; Hoskin DW
    Int J Immunopharmacol; 1998; 20(4-5):241-52. PubMed ID: 9730259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased cAMP and cAMP-dependent protein kinase activity mediate anti-CD2 induced suppression of anti-CD3-driven interleukin-2 production and CD25 expression.
    Lin J; Gettys TW; Qin L; Chavin KD; Yang Q; Ding Y; Punch JD; Bromberg JS
    Pathobiology; 1995; 63(4):175-87. PubMed ID: 8866788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective activation of extrathymic T cells in the liver by glycyrrhizin.
    Kimura M; Watanabe H; Abo T
    Biotherapy; 1992; 5(3):167-76. PubMed ID: 1419465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rescue of thymocytes and T cell hybridomas from glucocorticoid-induced apoptosis by stimulation via the T cell receptor/CD3 complex: a possible in vitro model for positive selection of the T cell repertoire.
    Iwata M; Hanaoka S; Sato K
    Eur J Immunol; 1991 Mar; 21(3):643-8. PubMed ID: 1826261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bidirectional control by glycyrrhizin of the growth response of lymphocytes stimulated through a receptor-bypassed pathway.
    Zhang YH; Isobe K; Iwamoto T; Nakashima I
    Immunol Lett; 1992 Apr; 32(2):147-52. PubMed ID: 1612638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD28 is an inducible T cell surface antigen that transduces a proliferative signal in CD3+ mature thymocytes.
    Turka LA; Ledbetter JA; Lee K; June CH; Thompson CB
    J Immunol; 1990 Mar; 144(5):1646-53. PubMed ID: 2155264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathway of signal delivery to murine thymocytes triggered by co-crosslinking CD3 and Thy-1 for cellular DNA fragmentation and growth inhibition.
    Nakashima I; Pu MY; Hamaguchi M; Iwamoto T; Rahman SM; Zhang YH; Kato M; Ohkusu K; Katano Y; Yoshida T
    J Immunol; 1993 Oct; 151(7):3511-20. PubMed ID: 8104221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.